These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 27103234

  • 1. Anti-Müllerian hormone and polycystic ovary syndrome.
    Bhide P, Homburg R.
    Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():38-45. PubMed ID: 27103234
    [Abstract] [Full Text] [Related]

  • 2. Interactions between androgens, FSH, anti-Müllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary.
    Dewailly D, Robin G, Peigne M, Decanter C, Pigny P, Catteau-Jonard S.
    Hum Reprod Update; 2016 Nov; 22(6):709-724. PubMed ID: 27566840
    [Abstract] [Full Text] [Related]

  • 3. Phenotypic variation in anti-Mullerian hormone (AMH) production per follicle in women with polycystic ovary syndrome (PCOS) and isolated polycystic ovarian morphology (PCOM): an observational cross-sectional study.
    Bhide P, Kulkarni A, Dilgil M, Dhir P, Shah A, Gudi A, Homburg R.
    Gynecol Endocrinol; 2017 Oct; 33(10):801-806. PubMed ID: 28454499
    [Abstract] [Full Text] [Related]

  • 4. The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.
    Alebić MŠ, Stojanović N, Duhamel A, Dewailly D.
    Hum Reprod; 2015 Aug; 30(8):1927-33. PubMed ID: 26048913
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Relationship between serum anti-Mullerian hormone and intrafollicular AMH levels in PCOS women.
    Stracquadanio M, Ciotta L, Palumbo MA.
    Gynecol Endocrinol; 2018 Mar; 34(3):223-228. PubMed ID: 28944702
    [Abstract] [Full Text] [Related]

  • 7. The physiology and clinical utility of anti-Mullerian hormone in women.
    Dewailly D, Andersen CY, Balen A, Broekmans F, Dilaver N, Fanchin R, Griesinger G, Kelsey TW, La Marca A, Lambalk C, Mason H, Nelson SM, Visser JA, Wallace WH, Anderson RA.
    Hum Reprod Update; 2014 Mar; 20(3):370-85. PubMed ID: 24430863
    [Abstract] [Full Text] [Related]

  • 8. The relationship between serum anti-Müllerian hormone levels and the follicular arrest for women with polycystic ovary syndrome.
    Li J, Li R, Yu H, Zhao S, Yu Y, Qiao J.
    Syst Biol Reprod Med; 2015 Apr; 61(2):103-9. PubMed ID: 25329139
    [Abstract] [Full Text] [Related]

  • 9. The role of AMH in anovulation associated with PCOS: a hypothesis.
    Homburg R, Crawford G.
    Hum Reprod; 2014 Jun; 29(6):1117-21. PubMed ID: 24770999
    [Abstract] [Full Text] [Related]

  • 10. [Anti-Mullerian hormone- its role in the pathogenesis of the polycystic ovary syndrome].
    Parahuleva N, Pehlivanov B, Dimitrakova E, Malinova M, Mladenova M.
    Akush Ginekol (Sofiia); 2012 Jun; 51(6):22-6. PubMed ID: 23390860
    [Abstract] [Full Text] [Related]

  • 11. The regulation and signalling of anti-Müllerian hormone in human granulosa cells: relevance to polycystic ovary syndrome.
    Dilaver N, Pellatt L, Jameson E, Ogunjimi M, Bano G, Homburg R, D Mason H, Rice S.
    Hum Reprod; 2019 Dec 01; 34(12):2467-2479. PubMed ID: 31735954
    [Abstract] [Full Text] [Related]

  • 12. Does AMH Reflect Follicle Number Similarly in Women with and without PCOS?
    Christiansen SC, Eilertsen TB, Vanky E, Carlsen SM.
    PLoS One; 2016 Dec 01; 11(1):e0146739. PubMed ID: 26799212
    [Abstract] [Full Text] [Related]

  • 13. Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.
    Pierre A, Peigné M, Grynberg M, Arouche N, Taieb J, Hesters L, Gonzalès J, Picard JY, Dewailly D, Fanchin R, Catteau-Jonard S, di Clemente N.
    Hum Reprod; 2013 Mar 01; 28(3):762-9. PubMed ID: 23321213
    [Abstract] [Full Text] [Related]

  • 14. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.
    Akush Ginekol (Sofiia); 2013 Mar 01; 52 Suppl 1():16-23. PubMed ID: 24294740
    [Abstract] [Full Text] [Related]

  • 15. Aberrant follicle development and anovulation in polycystic ovary syndrome.
    Franks S, Hardy K.
    Ann Endocrinol (Paris); 2010 May 01; 71(3):228-30. PubMed ID: 20362969
    [Abstract] [Full Text] [Related]

  • 16. Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age.
    Laven JS, Mulders AG, Visser JA, Themmen AP, De Jong FH, Fauser BC.
    J Clin Endocrinol Metab; 2004 Jan 01; 89(1):318-23. PubMed ID: 14715867
    [Abstract] [Full Text] [Related]

  • 17. Predictive markers for the FSH sensitivity of women with polycystic ovarian syndrome.
    Köninger A, Sauter L, Edimiris P, Kasimir-Bauer S, Kimmig R, Strowitzki T, Schmidt B.
    Hum Reprod; 2014 Mar 01; 29(3):518-24. PubMed ID: 24419495
    [Abstract] [Full Text] [Related]

  • 18. Anti-Müllerian hormone and ovarian dysfunction.
    Broekmans FJ, Visser JA, Laven JS, Broer SL, Themmen AP, Fauser BC.
    Trends Endocrinol Metab; 2008 Nov 01; 19(9):340-7. PubMed ID: 18805020
    [Abstract] [Full Text] [Related]

  • 19. Role of Anti-Müllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome.
    Dewailly D, Barbotin AL, Dumont A, Catteau-Jonard S, Robin G.
    Front Endocrinol (Lausanne); 2020 Nov 01; 11():641. PubMed ID: 33013710
    [Abstract] [Full Text] [Related]

  • 20. Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome.
    Du DF, Li XL, Fang F, Du MR.
    Gynecol Endocrinol; 2014 Nov 01; 30(12):885-9. PubMed ID: 25170777
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.